Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
THOMAS HOPE
🇨🇦
Canada
Country
🇨🇦
Canada
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients
Phase 2
Completed
Conditions
Prostate Cancer
Interventions
Drug: Ga-68 labeled HBED-CC PSMA
Device: Positron Emission Tomography (PET) image combined with Computed Tomography (CT) (PET/CT)
Device: Positron Emission Tomography (PET) image combined with Magnetic Resonance Imaging (MRI) (PET/MRI)
Subscribe
First Posted Date
2015-11-23
Last Posted Date
2020-12-22
Lead Sponsor
Thomas Hope
Target Recruit Count
225
Registration Number
NCT02611882
Locations
🇺🇸
University of California, San Francisco, San Francisco, California, United States
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy